California State Teachers Retirement System (CalSTRS)’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,476
Closed -$1.8K 3042
2025
Q1
$1.8K Hold
1,476
﹤0.01% 3023
2024
Q4
$1.9K Hold
1,476
﹤0.01% 3048
2024
Q3
$4.06K Hold
1,476
﹤0.01% 3029
2024
Q2
$3.34K Buy
+1,476
New +$4.48K ﹤0.01% 3049
2021
Q2
Sell
-56,068
Closed -$122K 3154
2021
Q1
$122K Hold
56,068
﹤0.01% 3013
2020
Q4
$126K Sell
56,068
-7,062
-11% -$18.5K ﹤0.01% 2979
2020
Q3
$169K Hold
63,130
﹤0.01% 2799
2020
Q2
$193K Hold
63,130
﹤0.01% 2736
2020
Q1
$124K Buy
63,130
+713
+1% +$1.74K ﹤0.01% 2747
2019
Q4
$179K Hold
62,417
﹤0.01% 2821
2019
Q3
$229K Buy
62,417
+12,765
+26% +$46.1K ﹤0.01% 2734
2019
Q2
$206K Buy
+49,652
New +$215K ﹤0.01% 2834
2015
Q2
Sell
-35,331
Closed -$118K 3013
2015
Q1
$118K Buy
35,331
+2,100
+6% +$7.5K ﹤0.01% 2968
2014
Q4
$115K Buy
33,231
+142
+0.4% +$628 ﹤0.01% 2992
2014
Q3
$166K Buy
33,089
+189
+0.6% +$1.47K ﹤0.01% 2942
2014
Q2
$454K Buy
+32,900
New +$410K ﹤0.01% 2556

Other funds holding GALT

California State Teachers Retirement System (CalSTRS)'s GALT Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Galectin Therapeutics (GALT) in Q2 2025, closing a stake of 1,476 shares — an estimated $1.8K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in GALT in Q2 2014 and held it in 16 quarters. The position peaked at $454K in Q2 2014. 86 funds tracked by Wall St. Rank hold GALT as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Galectin Therapeutics position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 1,476 Galectin Therapeutics shares in Q2 2025, an estimated $1.8K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Galectin Therapeutics in Q2 2014 and held it in 16 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Galectin Therapeutics position peaked at $454K in Q2 2014.
  • 86 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.